Renaissance Technologies's CVS Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 160,900 shares of CVS Health Corporation (CVS) worth $12.13 M, representing 0.02% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Renaissance Technologies has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2016, adding 3.65 M shares. Largest reduction occurred in Q2 2023, reducing 3.64 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2013 | +480,305 | New Buy | 480,305 | $56.75 |
| Q4 2013 | -480,305 | Sold Out | 480,305 | $0.00 |
| Q3 2015 | +854,505 | New Buy | 854,505 | $96.48 |
| Q4 2015 | -854,505 | Sold Out | 854,505 | $0.00 |
| Q1 2016 | +195,105 | New Buy | 195,105 | $103.73 |
| Q2 2016 | +3.65 M | Add 1869.25% | 3.84 M | $95.74 |
| Q3 2016 | -2.9 M | Reduce 75.53% | 940,005 | $88.99 |
| Q4 2016 | -215,500 | Reduce 22.93% | 724,505 | $78.91 |
| Q1 2017 | +689,500 | Add 95.17% | 1.41 M | $78.50 |
| Q2 2017 | -1.41 M | Sold Out | 1.41 M | $0.00 |
| Q4 2017 | +1.89 M | New Buy | 1.89 M | $72.50 |
| Q1 2018 | +30,800 | Add 1.63% | 1.92 M | $62.21 |
| Q2 2018 | -1.92 M | Sold Out | 1.92 M | $0.00 |
| Q4 2018 | +1.32 M | New Buy | 1.32 M | $65.52 |
| Q1 2019 | -1.02 M | Reduce 77.06% | 303,553 | $53.93 |
| Q2 2019 | -100,900 | Reduce 33.24% | 202,653 | $54.49 |
| Q3 2019 | +196,615 | Add 97.02% | 399,268 | $63.07 |
| Q4 2019 | -386,215 | Reduce 96.73% | 13,053 | $74.31 |
| Q1 2020 | +1.26 M | Add 9639.16% | 1.27 M | $59.33 |
| Q2 2020 | -192,069 | Reduce 15.11% | 1.08 M | $64.97 |
| Q3 2020 | +739,739 | Add 68.55% | 1.82 M | $58.40 |
| Q4 2020 | -1.82 M | Sold Out | 1.82 M | $0.00 |
| Q1 2021 | +1.79 M | New Buy | 1.79 M | $75.23 |
| Q2 2021 | -250,358 | Reduce 13.98% | 1.54 M | $83.44 |
| Q3 2021 | -1.23 M | Reduce 79.60% | 314,372 | $84.86 |
| Q4 2021 | -126,472 | Reduce 40.23% | 187,900 | $103.16 |
| Q1 2022 | +586,919 | Add 312.36% | 774,819 | $101.21 |
| Q2 2022 | +1.38 M | Add 178.09% | 2.15 M | $92.66 |
| Q3 2022 | -308,819 | Reduce 14.33% | 1.85 M | $95.37 |
| Q4 2022 | +715,600 | Add 38.77% | 2.56 M | $0.09 |
| Q1 2023 | +2.51 M | Add 97.93% | 5.07 M | $0.07 |
| Q2 2023 | -3.64 M | Reduce 71.88% | 1.43 M | $0.07 |
| Q3 2023 | -1.43 M | Sold Out | 1.43 M | $0.00 |
| Q4 2023 | +628,353 | New Buy | 628,353 | $78.96 |
| Q1 2024 | -628,353 | Sold Out | 628,353 | $0.00 |
| Q3 2024 | +967,153 | New Buy | 967,153 | $62.88 |
| Q4 2024 | -967,153 | Sold Out | 967,153 | $0.00 |
| Q1 2025 | +50,000 | New Buy | 50,000 | $67.75 |
| Q2 2025 | +532,853 | Add 1065.71% | 582,853 | $68.98 |
| Q3 2025 | -421,953 | Reduce 72.39% | 160,900 | $75.39 |
Renaissance Technologies's CVS Health Corporation Investment FAQs
Renaissance Technologies first purchased CVS Health Corporation (CVS) in Q3 2013, acquiring 480,305 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held CVS Health Corporation (CVS) for 49 quarters since Q3 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to CVS Health Corporation (CVS) was in Q2 2016, adding 3,842,105 shares worth $367.84 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 160,900 shares of CVS Health Corporation (CVS), valued at approximately $12.13 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CVS Health Corporation (CVS) represents approximately 0.02% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in CVS Health Corporation (CVS) was 5,069,953 shares, as reported at the end of Q1 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.